Bevacizumab in recurrent malignant glioma
- PMID: 18541118
- DOI: 10.1007/s11910-008-0035-9
Bevacizumab in recurrent malignant glioma
Comment on
-
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.Clin Cancer Res. 2007 Feb 15;13(4):1253-9. doi: 10.1158/1078-0432.CCR-06-2309. Clin Cancer Res. 2007. PMID: 17317837 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources